LSN 3213128
CAS No. 1941211-99-9
LSN 3213128( LSN3213128 )
Catalog No. M13043 CAS No. 1941211-99-9
LSN 3213128 is a novel potent, selective and orally-bioavailable antifolate with potent and specific inhibitory activity for AICARFT.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 336 | Get Quote |
|
| 50MG | 1674 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLSN 3213128
-
NoteResearch use only, not for human use.
-
Brief DescriptionLSN 3213128 is a novel potent, selective and orally-bioavailable antifolate with potent and specific inhibitory activity for AICARFT.
-
DescriptionLSN 3213128 is a novel potent, selective and orally-bioavailable antifolate with potent and specific inhibitory activity for AICARFT; results in dramatic elevation of 5-aminoimidazole 4-carboxamide ribonucleotide (ZMP) and growth inhibition in NCI-H460 and MDA-MB-231met2 cancer cell lines; demonstrates tumor growth inhibition in a murine based xenograft model of triple negative breast cancer (TNBC); Aminoimidazole-4-carboxamide ribonucleotide formyltransferase (AICARFT) is an enzyme in the purine biosynthetic pathway.
-
In Vitro——
-
In Vivo——
-
SynonymsLSN3213128
-
PathwayCell Cycle/DNA Damage
-
TargetAntifolate
-
RecptorAntifolate
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1941211-99-9
-
Formula Weight409.45
-
Molecular FormulaC17H16FN3O4S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (152.64 mM)
-
SMILESO=S(C1=CC=C(N2C[C@H](O)CC2)S1)(NC3=CC4=C(C=C3F)C=CNC4=O)=O
-
Chemical NameN-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Fales KR, et al. J Med Chem. 2017 Oct 26. doi: 10.1021/acs.jmedchem.7b01046.
molnova catalog
related products
-
Mirvetuximab
Mirvetuximab (M9346A) is a novel folate receptor α (FRα) monoclonal antibody targeting anti-FOLR1 (folate receptor 1).
-
Pemetrexed
A classical multitargeted antifolate that inhibits multiple folate-requiring enzymes TS/DHFR/GARFT with Ki of 1.3/7.2/65 nM respectively.
-
Trimetrexate
A quinazoline derivative and antifolate agent that fuctions as a dihydrofolate reductase (DHFR) inhibitor.
Cart
sales@molnova.com